赖氨酸是一种天然存在的α-氨基酸,在生物体中发挥着重要的作用,如蛋白质合成、能量代谢和免疫功能等。赖氨酸的化学结构特点是含有一个ε-氨基和两个羧基,并且具有两性性质。通过对其引入不同的官能团或改变其侧链,可以获得一系列具有不同生物学特性的衍生物。
二、制备方法赖氨酸类衍生物可以通过以下几种方式合成:
赖氨酸类衍生物广泛应用于医药、化工及食品等领域:
作为赖氨酸的一种常见形式,广泛用于饲料添加剂和营养补充品中。
2. 赖氨酸羟基异亮氨酸(LL-lysine)通过引入羟基异亮氨酸侧链而得到的新衍生物,在调节免疫功能等方面展现出独特的优势。
3. 赖氨酸酯类化合物通过与脂肪酸、醇等反应,形成赖氨酸酯类化合物,用于提高药物的溶解性和稳定性。
五、结论赖氨酸及其衍生物因其独特的化学性质和广泛的生物学应用前景,在多个领域中显示出巨大潜力。随着研究的不断深入和技术的进步,未来将有更多新型赖氨酸衍生物被开发出来,并为相关行业带来新的发展机遇。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
Fmoc-N’,N’,N’-三甲基-L-赖氨酸氯化物 | Fmoc-N-ε-(trimethyl)-L-lysine hydrochloride | 201004-29-7 | C24H31N2O4*Cl |
|
Fmoc-N'-甲基三苯甲基-L-赖氨酸 | (S)-6-[(Diphenyl-p-tolyl-methyl)-amino]-2-(9H-fluoren-9-ylmethoxycarbonylamino)-hexanoic acid | 167393-62-6 | C41H40N2O4 |
|
Fmoc-N'-乙酰基-L-赖氨酸 | Fmoc-Lys(OAc)-OH | 159766-56-0 | C23H26N2O5 |
|
Fmoc-N'-三氟乙酰基-L-赖氨酸 | Fmoc-Lys(Tfa)-OH | 76265-69-5 | C23H23F3N2O5 |
|
FMOC-赖氨酸 | Fmoc-Lys-OH | 105047-45-8 | C21H24N2O4 |
|
DL-赖氨酸盐酸盐 | 2,6-diaminohexanoic acid hydrochloride | 70-53-1 | C6H14N2O2*ClH |
|
DL-赖氨酸一水化合物 | DL-Lysine monohydrate | 885701-25-7 | C6H16N2O3 |
|
D-赖氨酸盐酸盐 | D-lysine monohydrochloride | 7274-88-6 | C6H14N2O2*ClH |
|
D-赖氨酸甲酯二盐酸盐 | (R)-Methyl 2,6-diaminohexanoate dihydrochloride | 67396-08-1 | C7H18Cl2N2O2 |
|
D-缬氨酰-L-白氨酰-L-赖氨酸对硝基苯胺二盐酸盐 | (S)-6-Amino-2-((S)-2-((R)-2-amino-3-methylbutanamido)-4-methylpentanamido)-N-(4-nitrophenyl)hexanamide dihydrochloride | 62354-43-2 | C23H40Cl2N6O5 |
|
Cbz-D-赖氨酸 | N-α-benzyloxycarbonyl-D-lysine | 70671-54-4 | C14H20N2O4 |
|
CBZ-L-赖氨酸甲酯盐酸盐 | methyl (2S)-2-amino-6-{[(benzyloxy)carbonyl]amino}hexanoate hydrochloride | 27894-50-4 | C15H22N2O4*ClH |
|
Boc-N'-(2-氯苄氧羰基)-D-赖氨酸 | N6-[[(2-Chlorophenyl)methoxy]carbonyl]-N2-[t-butyloxycarbonyl]-D-lysine | 57096-11-4 | C19H27ClN2O6 |
|
5-羟基-赖氨酸 | 2,6-diamino-5-hydroxy-hexanoic acid | 6000-08-4 | C6H14N2O3 |
|
5-羟基-DL-赖氨酸盐酸盐 | 5-hydroxylysine hydrochloride | 13204-98-3 | C6H14N2O3*ClH |
|
(S)-2-氨基-5-(1,3-二氧戊环-2-基)戊酸 | L-allysine ethylene acetal | 215054-80-1 | C8H15NO4 |
|
(S)-(-)-1-[N-(1-乙氧羰基-3-苯丙基)-N-三氟乙酰基]-L-赖氨酸 | N<sup>2</sup>-(1(R)-ethoxycarbonyl-3-phenylpropyl)-N<sup>6</sup>-trifluoroacetyl-L-lysine | 130414-30-1 | C20H27F3N2O5 |
|
(S)-(+)-2-氨基-3-(2-氨基乙氧基)丙酸赖氨酸 | L-4-oxalysine hydrochloride | 118021-35-5 | C5H12N2O3*ClH |
|
—— | (2S)-2-Amino-N-methylheptanamide | 28211-04-3 | C8H18N2O |
|
—— | (2S,5R)-2,6-Diamino-5-hydroxycaproic acid dihydrochloride | 172213-74-0 | C6H16Cl2N2O3 |
|
—— | Glycerophosphoinositol lysine | 425642-33-7 | C15H33N2O13P |
|
—— | H-DL-Lys-DL-Lys-DL-Lys-DL-Lys-DL-Lys-DL-Lys-DL-Lys-DL-Lys-DL-Lys-DL-Lys-DL-Lys-DL-Lys-DL-Lys-DL-Lys-DL-Lys-DL-Lys-DL-Lys-DL-Lys-DL-Lys-DL-Lys-NHBu.HBr | 26124-78-7 | C124H252BrN41O20 |
|
—— | E-(Boc)lysine | 2418-95-3 | C11H22N2O4 |
|
—— | L-Lysine,4-dinitrophenyl)-, monohydrochloride | 14401-10-6 | C12H16ClN4O6- |
|
—— | N~2~-(tert-butoxycarbonyl)-N~6~-formyllysine | 2483-47-8 | C12H22N2O5 |
|
—— | Z-Lys(Boc)-OSu | 3338-34-9 | C23H31N3O8 |
|
—— | 6-[(2-chlorophenyl)methoxycarbonylamino]-2-(9H-fluoren-9-ylmethoxycarbonylamino)hexanoic Acid | 133970-31-7 | C29H29ClN2O6 |
|
—— | N<sup>α</sup>-Methyl-L-lysin | 7431-89-2 | C7H16N2O2 |
|
—— | N2-[(benzyloxy)carbonyl]-N6-(tert-butoxycarbonyl)-L-lysine, compound with dicyclohexylamine (1:1) | 2212-76-2 | C12H23N*C19H28N2O6 |
|
—— | DL-<i>erythro</i>-5-hydroxy-lysine ; hydrochloride | 6505-25-5 | C6H14N2O3*ClH |
|
—— | D-glycero-D-guloheptonic acid | 504-91-6 | C6H14N2O3 |
|
—— | NSC89640 | 1655-49-8 | C18H18N6O10 |
|
—— | L-lysyl=>D-lysyl=>L-lysine | 13184-14-0 | C18H38N6O4 |
|
—— | Boc-Lys(2-chloro-Z)-OH | 54613-99-9 | C19H27ClN2O6 |
|
—— | Fmoc-Lys(Boc)-OH | 71989-26-9 | C26H32N2O6 |
|
—— | N<sup>ε</sup>-((2-azidoethoxy)carbonyl)-L-lysine | 1167421-25-1 | C9H17N5O4 |
|
—— | (S)-2-amino-6-(4-methylphenylsulfonamido)hexanoic acid | 2130-76-9 | C13H20N2O4S |
|
—— | (2S)-6-amino-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]-(2,2,2-trifluoroacetyl)amino]hexanoic acid | 130414-30-1 | C20H27F3N2O5 |
|
—— | 2-{[(Benzyloxy)(hydroxy)methylidene]amino}-6-({[(9H-fluoren-9-yl)methoxy](hydroxy)methylidene}amino)hexanoate | 105751-18-6 | C29H29N2O6- |
|
—— | trilysine | 25988-63-0 | C18H38N6O4 |
|
—— | 6-Amino-2-[(1-ethoxy-1-oxo-4-phenylbutan-2-yl)-(2,2,2-trifluoroacetyl)amino]hexanoic acid | 130414-30-1 | C20H27F3N2O5 |
|
—— | 1,1-dimethylethyl N6-{[(1,1-dimethylethyl)oxy]carbonyl}-L-lysinate hydrochloride | 13288-57-8 | C15H30N2O4*ClH |
|
—— | (R)-methyl 6-amino-2-(tert-butoxycarbonylamino)hexanoate | 55757-60-3 | C12H24N2O4 |
|
—— | 6-Amino-2-(2,6-diaminohexanoylamino)hexanoic acid;dihydrochloride | 52123-30-5 | C12H28Cl2N4O3 |
|
—— | N-ε-D-Cbz-lysine | 34404-32-5 | C14H20N2O4 |
|
—— | N-α-(tert-butoxycarbonyl)-L-lysine methyl ester | 55757-60-3 | C12H24N2O4 |
|
—— | Fmoc-Lys(ivDde)-OH | 204777-78-6 | C34H42N2O6 |
|
—— | 6150-68-1 | C6H14CaN2O2 |
|
|
—— | Fmoc-Lys(Dde)-OH | 150629-67-7 | C31H36N2O6 |
|
—— | L-lysine ethyl ester dihydrochloride | 33171-14-1 | C8H18N2O2*2ClH |
|